Literature DB >> 1396800

Guidelines for the use of implantable cardioverter defibrillators. A Task Force of the Working Groups on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology.

.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1396800

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  [Defibrillator therapy 1997. Prerequisites--results--prospects].

Authors:  H J Trappe
Journal:  Med Klin (Munich)       Date:  1997-07-15

2.  Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results.

Authors:  H F Pitschner; J Neuzner; E Himmrich; A Liebrich; J Jung; A Heisel
Journal:  J Interv Card Electrophysiol       Date:  1997-11       Impact factor: 1.900

3.  Guidelines as rationing tools: a qualitative analysis of psychosocial patient selection criteria for cardiac procedures.

Authors:  M K Giacomini; D J Cook; D L Streiner; S S Anand
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

4.  Surgery for postinfarction ventricular tachycardia in the pre-implantable cardioverter defibrillator era: early and long term outcomes in 100 consecutive patients.

Authors:  J P Bourke; R W Campbell; J M McComb; S S Furniss; J C Doig; C J Hilton
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

5.  Prevention of sustained ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators-the PREVENT study.

Authors:  Dietmar Wietholt; Volker Kuehlkamp; Ekkhard Meisel; Ellen Hoffmann; Christoph Stellbrink; Joerg Neuzner; Karl Seidl; Peter Szigat; Juergen Potratz
Journal:  J Interv Card Electrophysiol       Date:  2003-12       Impact factor: 1.900

Review 6.  Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.

Authors:  A Capucci; G Boriani
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.